Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.
JPMorgan Chase & Co. and its affiliates have become a substantial holder in Telix Pharmaceuticals Ltd, acquiring a 5.04% voting power with 16,881,167 ordinary shares. This position was reached on July 24, 2024, as detailed in a recent notice that outlines the nature and extent of JPMorgan’s relevant interests and associated entities.
For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.
